Firstly let me say I could be way off mark here. All this talk of regional licensing, I thought the golden goose was to sell to US Pharma, and that US Pharma would set the pricing benchmark. If any deals were done before that, I was of the belief that would limit the price that a US Pharma would pay. Am I off the mark here?
Firstly let me say I could be way off mark here. All this talk...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.000(0.00%) |
Mkt cap ! $273.4M | |||
| Open | High | Low | Value | Volume |
| $1.61 | $1.66 | $1.60 | $207.2K | 127.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 25510 | $1.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.64 | 12000 | 1 |
View Market Depth
| Last trade - 15.49pm 29/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |